PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Allarity Therapeutics, Inc.
Filed: February 24, 2023
Period of Report: February 24, 2023
Accession Number: 0001213900-23-014392

View Document ↗ View on SEC.gov ↗